Tag results:
CRISPR-Cas9
Cell Therapy News
Generation of SIV-Resistant T Cells and Macrophages from Nonhuman Primate Induced Pluripotent Stem Cells with Edited CCR5 Locus
[Stem Cell Reports] Scientists report successful targeting of the CCR5 locus in iPSCs generated from T cells or fibroblasts from Mauritian cynomolgus macaques, using CRISPR-Cas9 technology.
Muscle Cell News
RARG S427L Attenuates the DNA Repair Response to Doxorubicin in Induced Pluripotent Stem Cell-Derived Cardiomyocytes
[Stem Cell Reports] Scientists performed molecular dynamic simulations to determine the effect of missense variant rs2229774 on retinoic acid receptor gamma (RARG) structure and then validated these predictions using CRISPR-Cas9-genome-edited, induced pluripotent stem cell-derived cardiomyocytes.
Cancer Stem Cell News
FOXK2 Promotes Ovarian Cancer Stemness by Regulating the Unfolded Protein Response Pathway
[Journal of Clinical Investigation] Through comparative chromatin state and gene expression analyses in ovarian CSCs vs. non-CSCs, researchers identified FOXK2 as a highly expressed stemness-specific transcription factor in ovarian cancer.
Cancer Stem Cell News
Context-Specific Effects of NOX4 Inactivation in Acute Myeloid Leukemia (AML)
[Journal of Cancer Research and Clinical Oncology] Nox4 inactivation in normal HSCs and progenitor cells caused a minor reduction in HSC numbers and reconstitution capacity.
Human Immunology News
Human Induced-T-to-Natural Killer Cells Have Potent Anti-Tumor Activities
[Biomarker Research] Inactivation of BCL11B were performed by CRISPR/Cas9 in human T cells. Immunophenotypic and transcriptional profiles of sgBCL11B T cells were characterized by cytometer and transcriptomics, respectively.
Prostate Cell News
Targeting Autophagy in Prostate Cancer: Preclinical and Clinical Evidence for Therapeutic Response
[Journal of Experimental & Clinical Cancer Research] The authors provide a mechanistic discussion of autophagy in prostate cancer.